| Filed On | Filing |
|---|---|
| 09 Nov 2026 |
8-K: Results of Operations and Financial Condition
OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
BETHLEHEM, PA, August 5, 2026 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months e... |
| 11 Jun 2026 |
8-K: Other Events
On June 11, 2026, OraSure Technologies, Inc. (the “Company”) announced U.S. Food and Drug Administration (“FDA”) clearance of the Company’s Colli-Pee™•Dx Urine Collection Kit from its subsidiary DNA Genotek Inc., for use with Roche Molec... |
| 03 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
Exhibit 10.1 ORASURE TECHNOLOGIES, INC. STOCK AWARD PLAN ARTICLE 1 ESTABLISHMENT AND PURPOSE (Amended and Restated Effective as of April 20, 2026) Establishment. Epitope, Inc. established this Plan as the Epitope, Inc. 2000 Stock Award P... |
| 06 May 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, May 6, 2026 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ende... |
| 17 Apr 2026 |
8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
This Cooperation Agreement (this “Agreement”) is made and entered into as of April 16, 2026, by and between OraSure Technologies, Inc., a Delaware corporation (the “Company”), on the one hand, and Altai Capital Management, L.P., a Delawa... |
| 30 Mar 2026 |
8-K: Regulation FD Disclosure
OraSure: The Facts Altai Capital has made several misleading claims that serve as the basis for its efforts to replace two independent directors on OraSure’s Board. This presentation sets the record straight on the facts. March 2026 Exhi... |
| 05 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 28, 2026, David J. Shulkin, M.D. notified the board of directors (the “Board”) of OraSure Technologies, Inc. (the “Company”) of his decision to resign from his position as director, including his position as a member of the C... |
| 25 Feb 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, February 25, 2026 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three month... |
| 05 Jan 2026 |
8-K: Regulation FD Disclosure; Other Events
BETHLEHEM, PA, January 5, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted tw... |
| 01 Dec 2025 |
8-K: Other Events
On December 1, 2025, OraSure Technologies, Inc. (the “Company”) reported that each of Carrie Eglinton Manner, President, Chief Executive Officer and Director, and Kenneth McGrath, Chief Financial Officer, adopted separate Rule 10b5-1 tra... |
| 05 Nov 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, November 5, 2025 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months... |
| 28 Oct 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Resignation of Mara G. Aspinall; Appointment of John P. Kenny as Chair of the Board |
| 05 Aug 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, August 5, 2025 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months e... |
| 14 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
ORASURE TECHNOLOGIES, INC. STOCK AWARD PLAN ARTICLE 1 ESTABLISHMENT AND PURPOSE (Amended and Restated Effective as of March 24, 2025) Establishment. Epitope, Inc. established this Plan as the Epitope, Inc. 2000 Stock Award Plan, effectiv... |
| 09 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On May 8, 2025, Kathleen G. Weber notified OraSure Technologies, Inc. (the “Company”) of her resignation as Chief Product Officer of the Company, effective June 30, 2025. Ms. Weber’s resignation will be treated as a resignation for “Good... |
| 07 May 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, May 7, 2025 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ende... |
| 24 Mar 2025 |
8-K: Other Events
BETHLEHEM, PA, March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors... |
| 25 Feb 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BETHLEHEM, PA, February 25, 2025 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three month... |
| 26 Dec 2024 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets
On December 19, 2024, OraSure Technologies, Inc., a Delaware corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with, Project Watson Merger Sub, Inc., a Delaware corporation and a wholly-own... |
Loading...